Beijing (1)

Acute Lymphoblastic Leukemia (1)

Acute Lymphoblastic Leukemia, in Relapse (1)

Refractory Acute Lymphoid Leukemia (1)

Recruiting (1)

phase 2 (1)

Beijing Boren Hospital (1)

chimeric antigen receptor t cell (1)

biological (1)

Other (1)

Interventional (1)

refractory acute lymphoid leukemia

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Aug 12, 2022